Literature DB >> 16969585

Solution structure and phosphopeptide binding of the SH2 domain from the human Bruton's tyrosine kinase.

Kuo-Chun Huang1, Hsi-Tsung Cheng, Ming-Tao Pai, Shiou-Ru Tzeng, Jya-Wei Cheng.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16969585     DOI: 10.1007/s10858-006-9064-3

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


× No keyword cloud information.
  21 in total

Review 1.  Btk and BLNK in B cell development.

Authors:  S Tsukada; Y Baba; D Watanabe
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

Review 2.  Searching for specificity in SH domains.

Authors:  J E Ladbury; S Arold
Journal:  Chem Biol       Date:  2000-01

Review 3.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

4.  MOLMOL: a program for display and analysis of macromolecular structures.

Authors:  R Koradi; M Billeter; K Wüthrich
Journal:  J Mol Graph       Date:  1996-02

5.  Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.

Authors:  J M Bradshaw; V Mitaxov; G Waksman
Journal:  J Mol Biol       Date:  1999-11-05       Impact factor: 5.469

6.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology.

Authors:  G Cornilescu; F Delaglio; A Bax
Journal:  J Biomol NMR       Date:  1999-03       Impact factor: 2.835

7.  Spectral density function mapping using 15N relaxation data exclusively.

Authors:  N A Farrow; O Zhang; A Szabo; D A Torchia; L E Kay
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

8.  1H, 15N and 13C resonance assignments of the SH2 domain of Bruton's tyrosine kinase.

Authors:  Ming-Tao Pai; Kuo-Chun Huang; Shiou-Ru Tzeng; Jya-Wei Cheng
Journal:  J Biomol NMR       Date:  2002-10       Impact factor: 2.835

9.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

10.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

Authors:  S Tsukada; D C Saffran; D J Rawlings; O Parolini; R C Allen; I Klisak; R S Sparkes; H Kubagawa; T Mohandas; S Quan
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

View more
  5 in total

Review 1.  The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.

Authors:  Leslie J Crofford; Lindsay E Nyhoff; Jonathan H Sheehan; Peggy L Kendall
Journal:  Expert Rev Clin Immunol       Date:  2016-03-04       Impact factor: 4.473

2.  Achieving a Graded Immune Response: BTK Adopts a Range of Active/Inactive Conformations Dictated by Multiple Interdomain Contacts.

Authors:  Raji E Joseph; Thomas E Wales; D Bruce Fulton; John R Engen; Amy H Andreotti
Journal:  Structure       Date:  2017-08-31       Impact factor: 5.006

3.  Conformational snapshots of Tec kinases during signaling.

Authors:  Raji E Joseph; Amy H Andreotti
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

4.  Btk SH2-kinase interface is critical for allosteric kinase activation and its targeting inhibits B-cell neoplasms.

Authors:  Daniel P Duarte; Allan J Lamontanara; Giuseppina La Sala; Sukyo Jeong; Yoo-Kyoung Sohn; Alejandro Panjkovich; Sandrine Georgeon; Tim Kükenshöner; Maria J Marcaida; Florence Pojer; Marco De Vivo; Dmitri Svergun; Hak-Sung Kim; Matteo Dal Peraro; Oliver Hantschel
Journal:  Nat Commun       Date:  2020-05-08       Impact factor: 14.919

5.  Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.

Authors:  Shruti Sharma; Natalie Galanina; Ailin Guo; Jimmy Lee; Sabah Kadri; Charles Van Slambrouck; Bradley Long; Weige Wang; Mei Ming; Larissa V Furtado; Jeremy P Segal; Wendy Stock; Girish Venkataraman; Wei-Jen Tang; Pin Lu; Yue Lynn Wang
Journal:  Oncotarget       Date:  2016-10-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.